Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial
Titel:
Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial
Auteur:
Mina, Roberto Musto, Pellegrino Rota-Scalabrini, Delia Paris, Laura Gamberi, Barbara Palmas, Angelo Aquino, Sara de Fabritiis, Paolo Giuliani, Nicola De Rosa, Luca Gozzetti, Alessandro Cellini, Claudia Bertamini, Luca Capra, Andrea Oddolo, Daniela Vincelli, Iolanda Donatella Ronconi, Sonia Pavone, Vincenzo Pescosta, Norbert Cea, Michele Fioritoni, Francesca Ballanti, Stelvio Grasso, Mariella Zamagni, Elena Belotti, Angelo Boccadoro, Mario Gay, Francesca